Search Results - "Fortes González, S"

1ISG-030 Economic impact of biological medicines on a third level hospital by Fortes González, S, Vazquez Blanco, S, Herrero Poch, L, De Miguel Bouzas, JC, Castro Dominguez, JM, Villamayor Blanco, L

“…Background and importanceHigh costs of biological medicines (BM) are a financial issue for hospitals. The arrival of biosimilar drugs (BS) improved their…”
Get full text

5PSQ-061 Alemtuzumab for relapsing–remitting multiple sclerosis: effectiveness and safety by Vázquez Blanco, S, Fortes González, S, Herrero Poch, L, De Miguel Bouzas, JC, Castro Domínguez, JM, Villamayor Blanco, L

“…Background and importanceAlemtuzumab is a humanised monoclonal antibody that selectively targets CD52, indicated in adult patients with relapsing–remitting…”
Get full text

CP-203 Safety of paclitaxel albumin bound nanoparticles plus gemcitabina in metastasic pancreatic adenocarcinoma by Blanco, S Vázquez, González, MS Fortes, Ribeiro, MF Fernández, Mayo, ME Garcia, Freire, L González, Fernández, R Olivera, Crespo-Diz, C

“…BackgroundPaclitaxel albumin bound nanoparticles (nab-Paclitaxel) is indicated for the treatment of metastasic pancreatic adenocarcinoma (MPA). In clinical…”
Get full text

Imatinib en leucemia mieloide crónica: resultados en práctica clínica habitual by Fortes-González, MS, Vazquez-Blanco, Crespo-Diz, Amador-Barciela

“…Resumen Objetivos: Imatinib cambió el paradigma de la leucemia mieloide crónica (LMC), tras lograr en los ensayos clínicos frente a interferón mejor tasa de…”
Get full text

PKP-032 Pharmacokinetically guided dose adjustment of digoxin in institutionalised patients by Gonzalez, MS Fortes, Vieitez, A Ballester, Poch, L Herrero, Blanco, S Vázquez, Crespo-Diz, C

“…BackgroundDeterioration in renal function occurs with ageing and can affect drug pharmacokinetics, decreasing elimination. Furthermore, the narrow therapeutic…”
Get full text